IMMUNOGENICITY
Clinical trials for IMMUNOGENICITY explained in plain language.
Never miss a new study
Get alerted when new IMMUNOGENICITY trials appear
Sign up with your email to follow new studies for IMMUNOGENICITY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Single-dose HPV vaccine showdown: can CERVAVAC match gardasil?
⭐️ VACCINE ⭐️ Not yet recruitingThis study tests whether one dose of the CERVAVAC HPV vaccine works as well as one dose of the Gardasil vaccine. About 1,266 girls, boys, and young women in Zambia will receive a single shot and have their immune response checked at 6, 12, and 24 months. The goal is to see if CER…
Matched conditions: IMMUNOGENICITY
Phase: PHASE4 • Sponsor: International Agency for Research on Cancer • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 12, 2026 12:03 UTC
-
New eye injection PRO-169 under safety review for Diabetes-Related vision loss
Knowledge-focused Not yet recruitingThis early-stage study tests whether PRO-169, an eye injection for diabetic macular edema, is safe by checking if the body creates antibodies against it. About 60 adults with diabetes will receive one injection, and researchers will monitor for immune reactions and side effects. …
Matched conditions: IMMUNOGENICITY
Phase: PHASE1 • Sponsor: Laboratorios Sophia S.A de C.V. • Aim: Knowledge-focused
Last updated Jun 16, 2026 22:22 UTC